JP2025515559A5 - - Google Patents

Info

Publication number
JP2025515559A5
JP2025515559A5 JP2024557894A JP2024557894A JP2025515559A5 JP 2025515559 A5 JP2025515559 A5 JP 2025515559A5 JP 2024557894 A JP2024557894 A JP 2024557894A JP 2024557894 A JP2024557894 A JP 2024557894A JP 2025515559 A5 JP2025515559 A5 JP 2025515559A5
Authority
JP
Japan
Prior art keywords
aqueous
ticagrelor
cyclodextrin
ticagrelol
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515559A (ja
Filing date
Publication date
Priority claimed from PCT/EP2022/063185 external-priority patent/WO2023222184A1/en
Application filed filed Critical
Priority claimed from PCT/EP2023/063071 external-priority patent/WO2023222660A1/en
Publication of JP2025515559A publication Critical patent/JP2025515559A/ja
Publication of JP2025515559A5 publication Critical patent/JP2025515559A5/ja
Pending legal-status Critical Current

Links

JP2024557894A 2022-05-16 2023-05-16 チカグレロル水溶液、その製造方法および使用 Pending JP2025515559A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/EP2022/063185 WO2023222184A1 (en) 2022-05-16 2022-05-16 Aqueous ticagrelor solution, method of manufacturing and uses
EPPCT/EP2022/063185 2022-05-16
EPPCT/EP2023/055736 2023-03-07
EP2023055736 2023-03-07
PCT/EP2023/063071 WO2023222660A1 (en) 2022-05-16 2023-05-16 Aqueous ticagrelor solutions, method of manufacturing and uses

Publications (2)

Publication Number Publication Date
JP2025515559A JP2025515559A (ja) 2025-05-20
JP2025515559A5 true JP2025515559A5 (cg-RX-API-DMAC10.html) 2026-05-14

Family

ID=86604209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557894A Pending JP2025515559A (ja) 2022-05-16 2023-05-16 チカグレロル水溶液、その製造方法および使用

Country Status (9)

Country Link
US (1) US20250235455A1 (cg-RX-API-DMAC10.html)
EP (1) EP4525931A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025515559A (cg-RX-API-DMAC10.html)
KR (1) KR20250024925A (cg-RX-API-DMAC10.html)
CN (1) CN119212736A (cg-RX-API-DMAC10.html)
AU (1) AU2023271339A1 (cg-RX-API-DMAC10.html)
CA (1) CA3252689A1 (cg-RX-API-DMAC10.html)
MX (1) MX2024013807A (cg-RX-API-DMAC10.html)
WO (1) WO2023222660A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260113060A (ko) * 2023-11-16 2026-07-21 하이로리스 디벨롭먼츠 에스에이 피부경유 관상동맥 중재술 (pci)을 겪은 환자에서 허혈성 사건의 치료, 감소 또는 예방에 사용을 위한 티카그렐러 iv
WO2025104274A1 (en) * 2023-11-16 2025-05-22 Hyloris Developments Sa Ticagrelor iv for use in the prevention of thromboembolic events
AU2024386725A1 (en) * 2023-11-22 2026-04-30 Hyloris Developments Sa Intravenous administration of ticagrelor compositions in a patient who was previously administered an opioid in order to treat coagulation and avoid reduced ticagrelor uptake
CN117919246A (zh) * 2024-01-26 2024-04-26 重庆东得医药科技有限公司 一种以左西孟旦为活性成分的组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3100728T3 (pl) * 2009-05-13 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje farmaceutyczne zawierające prasugrel i pochodne cyklodekstryny oraz sposoby ich wytwarzania i zastosowania
CN110917167A (zh) * 2018-09-19 2020-03-27 河南天晟泰丰医药科技有限公司 替格瑞洛肠溶缓释软胶囊及其制备方法
WO2021096444A1 (en) * 2019-11-13 2021-05-20 Santa Farma İlaç Sanayi̇ A.Ş. Pharmaceutical compositions comprising ticagrelor

Similar Documents

Publication Publication Date Title
US6468989B1 (en) Gel compositions containing metronidazole
JPS61500788A (ja) 水に不安定なまたは僅かに溶解性の薬物を含有する医薬調製物およびその製造方法
CN100411624C (zh) 包含甲硝唑的含水组合物
JPH0819004B2 (ja) 徐放性医薬製剤
HU203967B (en) Process for producing granulated pharmaceutical compositions
Topuz Rapid sublingual delivery of piroxicam from electrospun cyclodextrin inclusion complex nanofibers
CN108261398A (zh) 一种含有左西孟旦的供注射用药物制剂及其制备方法
CN104414983B (zh) 一种注射用福沙匹坦二甲葡胺无菌冻干粉末及其制备工艺
CN119212736A (zh) 水性替格瑞洛溶液、生产方法及用途
CN114845701A (zh) 1-(5-(2,4-二氟苯基)-1-((3-氟苯基)磺酰基)-4-甲氧基-1h-吡咯-3-基)-n-甲基甲胺的液体药物组合物
JP3597239B2 (ja) 安定な点眼剤
JP2022520779A5 (cg-RX-API-DMAC10.html)
CN107126564A (zh) 一种白蛋白结合型索拉非尼纳米制剂及其制备方法
JPH07165616A (ja) シクロデキストリンの複合組成物及び複合化法
DE60018744T2 (de) Komplex von Eletriptan und Sulfobutylether-cyclodextrin und dessen Verwendung zur Behandlung von Migräne
KR100726720B1 (ko) 수난용성 활성물질을 하이드록시알킬화 사이클로덱스트린과리포좀으로 이중 안정화 시킨 나노캡슐 리포좀 조성물
JP2018529772A (ja) プロピオン酸クロベタゾールを含有する自己発泡性洗浄組成物、及び乾癬の処置におけるその使用
CA2600969A1 (en) Soft gelatin capsules containing cyclodextrin in the capusle shell
HUT72055A (en) Ciklodextrin-vinpocetin complexes process for producing them and pharmaceutical compositions containing them
Singh et al. Cyclodextrin as Solubilizer and Targeting Agent for Drugs
JP2009051808A (ja) 非晶質ナノ薬物の製造方法、装置、非晶質ナノ薬物、及び、分子分散薬物の製造方法、分子分散薬物
EP2651518B1 (en) Oral compositions and method for producing thereof
TW202237085A (zh) 眼用組合物
TWI625130B (zh) 凝膠基質及凝膠製劑
CN105596304A (zh) 用于减缓周边血管疾病病患间歇性跛行症状的属喹啉酮衍生物的西洛他唑的新颖调配物